Potential biomarkers for monitoring therapeutic response in patients with CIDP

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome

(2009) Krista Kuitwaard et al.   ANNALS OF NEUROLOGY

Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies

(2009) Grace Lee et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP

(2009) M. Iijima et al.   NEUROLOGY

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study

(2009) I.S.J. Merkies et al.   NEUROLOGY

Impaired inhibitory Fc  receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

(2009) B. Tackenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

(2008) I. Elovaara et al.   EUROPEAN JOURNAL OF NEUROLOGY

Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

(2008) Richard AC Hughes et al.   LANCET NEUROLOGY